Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Total Current Liabilities (2020 - 2026)

Updated

Barinthus Biotherapeutics (BRNS) recorded Total Current Liabilities of $11.42 million in Q2 2026, down 10.2% from $12.73 million a year earlier and down 4.8% from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Barinthus Biotherapeutics reported Total Current Liabilities of $10.02 million, down 36.0% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 5.6% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $15.66 million in FY2024 (+24.3%), $12.6 million in FY2023 (+2.9%), $12.24 million in FY2022 (+9.7%) and $11.16 million in FY2021 (+46.0%).
  • Quarterly Total Current Liabilities has ranged from $6.37 million in Q3 2021 to $18.57 million in Q3 2023 over the past five years.
  • On a year-over-year basis, Total Current Liabilities rose in two of the last eight quarters, with an average decline of 11.8%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 120.2% in Q3 2022, against a decline of 36.0% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $12 million (Q1 2026), $10.02 million (Q4 2025) and $10.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - 11.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.42 Mn
Mar 31, 2026 12.00 Mn
Dec 31, 2025 10.02 Mn
Sep 30, 2025 10.80 Mn
Jun 30, 2025 12.73 Mn
Mar 31, 2025 11.98 Mn
Dec 31, 2024 15.66 Mn
Sep 30, 2024 15.07 Mn
Jun 30, 2024 15.59 Mn
Mar 31, 2024 12.84 Mn
Dec 31, 2023 12.60 Mn
Sep 30, 2023 18.57 Mn
Jun 30, 2023 12.11 Mn
Mar 31, 2023 11.99 Mn
Dec 31, 2022 12.24 Mn
Sep 30, 2022 14.03 Mn
Jun 30, 2022 12.17 Mn
Mar 31, 2022 16.48 Mn
Dec 31, 2021 11.16 Mn
Sep 30, 2021 6.37 Mn
API Access

Barinthus Biotherapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BRNS&period=max&api_key=YOUR_API_KEY